CCR6 and cancer: The CD27 and CD70 costimulatory pathway has been found to inhibit the transcription of the key effector molecules IL-17 and the chemokine receptor CCR6, subsequently attenuates associated autoimmunity, Cancer cells can reprogramme their metabolism to support cell growth and proliferation.